Wien, Austria

Andrej Muranyi

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Andrej Muranyi

Introduction

Andrej Muranyi is a notable inventor based in Wien, Austria. He has made significant contributions to the field of coagulation factor preparations, particularly with his innovative processes that enhance the purity and activation of these essential components in medical applications.

Latest Patents

Andrej Muranyi holds a patent for the "FX activation process and its use in the preparation of a FXa composition." This invention focuses on a high purity Coagulation Factor Xa (FXa) preparation and outlines an activation and purification process that achieves high purity and a high degree of activation without the need for proteinaceous activators during manufacturing. His work in this area is crucial for advancing medical treatments that rely on coagulation factors.

Career Highlights

Andrej is currently employed at Octapharma AG, a company renowned for its commitment to developing and producing high-quality human proteins for treating various medical conditions. His role at Octapharma AG allows him to apply his expertise in coagulation factors and contribute to the company's innovative projects.

Collaborations

Andrej has collaborated with several professionals in his field, including Juergen Roland Roemisch and Katharina Pock. These collaborations have likely enriched his research and development efforts, leading to advancements in coagulation factor preparations.

Conclusion

Andrej Muranyi's contributions to the field of coagulation factors through his innovative patent and work at Octapharma AG highlight his importance as an inventor. His dedication to improving medical treatments through high-purity preparations is commendable and reflects the ongoing advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…